Effects of acute and chronic administration of venlafaxine and desipramine on extracellular monoamine levels in the mouse prefrontal cortex and striatum-Reference-Cited by-同舟云学术

Effects of acute and chronic administration of venlafaxine and desipramine on extracellular monoamine levels in the mouse prefrontal cortex and striatum

Published:2014-04 Issue: Volume:729 Page:86-93
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Higashino Kosuke,Ago Yukio,Umehara Masato,Kita Yuki,Fujita Kazumi,Takuma Kazuhiro,Matsuda Toshio

Funder

JSPS KAKENHI

Publisher

Elsevier BV

Subject

Pharmacology

Reference33 articles.

1. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice;Ago;Synapse,2007

2. Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and σ1 receptor activation;Ago;Psychopharmacology,2011

3. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors;Bymaster;Neuropsychopharmacology,2001

4. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals;Carboni;J. Neurochem.,1990

5. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism;Dawson;Neuropharmacology,1999

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AMPA receptors modulate enhanced dopamine neuronal activity induced by the combined administration of venlafaxine and brexpiprazole;Neuropsychopharmacology;2024-08-15

2. Physiological analyses of swallowing changes due to chronic obstructive pulmonary disease in anesthetized male rats;Frontiers in Physiology;2024-08-07

3. Valid and Invalid Designs for Conducting Drug-Discrimination Experiments in Abuse Potential Evaluations;Drug and Alcohol Dependence;2024-07

4. Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine;Psychopharmacology;2022-08-10

5. Complicated Role of Exercise in Modulating Memory: A Discussion of the Mechanisms Involved;Neurochemical Research;2022-02-23